##plugins.themes.academic_pro.article.sidebar##

Download
pdf

##plugins.themes.academic_pro.article.main##

Abstract

The loss of a pregnancy before the fetus is viable is referred to as a miscarriage. Depending on the data source, this might be considered as being 20 or 24 weeks pregnant. Threatened miscarriage occurs during the first 20 weeks of pregnancy, with pain or without pain. A miscarriage occurs in 10% to 15% of all clinically confirmed pregnancies. Recurrent miscarriages, typically defined as three or more spontaneous miscarriages, affect 1% to 2% of couples. There may never be a cure for recurrent miscarriage for many women and their partners. Pregnancies may now be identified sooner, even if they are going to end in an early miscarriage, thanks to advancements in pregnancy testing and ultrasound technology. These may not have been noticed in the past. Consequently, more women may report losing an early pregnancy. Both couples may experience severe emotional grief if a miscarriage occurs. Initial emotional numbness and denial, anxiety, shock, grief, emptiness, rage, inadequacy, blame, and envy, melancholy, sleep trouble, social isolation, hostility, and marital conflict have all been documented as emotional responses to pregnancy losses

Keywords

Recurrent miscarriages Fertility hormones

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite
Dr. Rehab Jasim Mohammed, & Asst.Lect. Aseel Ehsan Mahmoud. (2023). Relation of recurrent miscarriages with some of fertility hormones. Texas Journal of Agriculture and Biological Sciences, 17, 109–113. Retrieved from https://zienjournals.com/index.php/tjabs/article/view/4189

References

  1. Cocksedge, K. A., Li, T. C., Saravelos, S. H., & Metwally, M. (2008). A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage. Reproductive biomedicine online, 17(1), 151-160. 2. Ehterami, A., Khastar, H., Soleimannejad, M., Salehi, M., Nazarnezhad, S., Majidi Ghatar, J., ... & Shariatifar, N. (2021). Bone regeneration in rat using polycaprolactone/gelatin/epinephrine scaffold. Drug Development and Industrial Pharmacy, 47(12), 1915-1923.
  2. Habbema, J. D. F., Eijkemans, M. J., Leridon, H., & te Velde, E. R. (2015). Realizing a desired family size: when should couples start?. Human Reproduction, 30(9), 2215-2221. 4. Garcia, D., Brazal, S., Rodriguez, A., Prat, A., & Vassena, R. (2018). Knowledge of age-related fertility decline in women: A systematic review. European Journal of Obstetrics & Gynecology and Reproductive Biology, 230, 109-118
  3. Wu, H. L., Marwah, S., Wang, P., Wang, Q. M., & Chen, X. W. (2017). Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis. Scientific reports, 7(1), 1-9.
  4. Dutta, UR, Rajitha, P., Pidugu, VK, & Dalal, AB (2011). Cytogenetic abnormalities in 1162 couples with recurrent miscarriages in the southern region of India: report and review. Journal of assisted reproduction and genetics , 28 (2), 145-149.
  5. Bulletti, C., Flamigni, C., & Giacomucci, E. (1996). Reproductive failure due to spontaneous abortion and recurrent miscarriage. Human Reproduction Update, 2(2), 118-136.
  6. Metwally, M., Li, T. C., & Ledger, W. L. (2007). The impact of obesity on female reproductive function. Obesity Reviews, 8(6), 515-523.
  7. Ibrahim, F. M., Al Awar, S. A. A. R., Nayeri, N. D., Al-Jefout, M., Ranjbar, F., & Moghadam, Z. B. (2018). Experiences of Recurrent Pregnancy Loss Through the Perspective of United Arab Emirates Women: A Qualitative Study. International Journal of Women's Health and Reproduction Sciences, 7, 306-312.
  8. Ortiz-Flores, A. E., Luque-Ramírez, M., & Escobar-Morreale, H. F. (2019). Polycystic ovary syndrome in adult women. Medicina Clínica (English Edition), 152(11), 450-457.
  9. Baskind, N. E., & Balen, A. H. (2016). Hypothalamic–pituitary, ovarian and adrenal contributions to polycystic ovary syndrome. Best Practice & Research Clinical Obstetrics & Gynaecology, 37, 80-97.
  10. Hidalgo-Lopez, E., Mueller, K., Harris, T., Aichhorn, M., Sacher, J., & Pletzer, B. (2020). Human menstrual cycle variation in subcortical functional brain connectivity: a multimodal analysis approach. Brain Structure and Function, 225(2), 591-605.
  11. Abdelmgeed, A., & Ali, T. M. (2018). Sex Hormone Abnormalities in Epileptic Saudi Women. AUMJ, 5(1), 27-34.
  12. Coss, D., Jacobs, S. B., Bender, C. E., & Mellon, P. L. (2004). A novel AP-1 site is critical for maximal induction of the follicle-stimulating hormone β gene by gonadotropin-releasing hormone. Journal of Biological Chemistry, 279(1), 152-162.
  13. Gingold, JA, Lee, JA, Whitehouse, MC, Rodriguez-Purata, J., Sandler, B., Grunfeld, L., ... & Copperman, AB (2015). Maximum basal FSH predicts reproductive outcomes better than cycle - specific basal FSH levels: waiting for a "better" month conveys limited retrieval benefits.
  14. Chateau, D., Geiger, JM, Samama, B., & Boehm, N. (1996). Vaginal keratinization during the estrous cycle in rats: a model for evaluating retinoid activity. Skin Pharmacology and Physiology , 9 (1), 9-16 .
  15. Rastrelli, G., Corona, G., Mannucci, E., & Maggi, M. (2014). Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta‐analytic study. Andrology , 2 (6), 794-808.
  16. Andersen, C. Y., Westergaard, L. G., & van Wely, M. (2004). FSH isoform composition of commercial gonadotrophin preparations: a neglected aspect?. Reproductive biomedicine online, 9(2), 231-236.
  17. Ramasamy, R., Bakırcıoğlu, ME, Cengiz, C., Karaca, E., Scovell, J., Jhangiani, S. N., ... & Lamb, DJ (2015). Whole-exome sequencing identifies novel homozygous mutation in NPAS2 in family with nonobstructive azoospermia. Fertility and sterility , 104 (2), 286-291.
  18. Callard, G. V., Tarrant, A. M., Novillo, A., Yacci, P., Ciaccia, L., Vajda, S., ... & Cotter, K. A. (2011). Evolutionary origins of the estrogen signaling system: insights from amphioxus. The Journal of steroid biochemistry and molecular biology, 127(3-5), 176-188.
  19. Coad, J., Pedley, K., & Dunstall, M. (2019). Anatomy and physiology for midwives e-book. Elsevier Health Sciences.
  20. Hess, R. A. (2003). Estrogen in the adult male reproductive tract: a review. Reproductive Biology and Endocrinology, 1(1), 1-14.
  21. Bondesson, M., Hao, R., Lin, C. Y., Williams, C., & Gustafsson, J. Å. (2015). Estrogen receptor signaling during vertebrate development. Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms, 1849(2), 142-151.
  22. Hammond, K. R. (2002). Meniru GI Cambridge guide to infertility management and assisted reproduction. Cambridge, United Kingdom: Cambridge University Press, 2001: 1–276. $47.95. Fertility and Sterility, 78(2), 445.
  23. Olooto, W. E., Adeleye, A. O., Amballi, A. A., & Mosuro, A. O. (2012). Pattern of reproductive hormones (follicle stimulating hormone, luteinizing hormone, estradiol, progesterone, and prolactin) levels in infertile women in Sagamu South Western Nigeria. Der Pharmacia Lettre, 4(2), 549-553.
  24. Gerlo, S., Davis, J. R., Mager, D. L., & Kooijman, R. (2006). Prolactin in man: a tale of two promoters. Bioessays, 28(10), 1051-1055.
  25. Mortini, P., Nocera, G., Roncelli, F., Losa, M., Formenti, A. M., & Giustina, A. (2020). The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): A surgical perspective. Reviews in Endocrine and Metabolic Disorders, 21(4), 527-536.
  26. Isong, I., Okhormhe, Z., Eze-Bassey, I., Okpokam, D., & Usoro, C. (2016). Levels of prolactin, progesterone, estradiol, luteinizing hormone and follicle stimulating hormone in infertile women in Calabar, Nigeria. International Journal of Reproduction, Contraception Obstetrics and Gynecology, 5(3), 804.
  27. Marrag, I., Hajji, K., Braham, M. Y., Dhifallah, M., & Nasr, M. (2015). Antipsychotics and hyperprolactinemia: prevalence and risk factors. Ann Psychiatry Ment Health, 3(6), 1047.
  28. Wilcox, A. J. (2010). Fertility and Pregnancy: An Epidemiologic Perspective. Oxford: Oxford University Press.
  29. EGBAGBA, A.O. (2016). ASSESSMENT OF SERUM, FOLLICLE STIMULATING HORMONE, LUTEINIZING HORMONE, OESTRADIOL, PROGESTERONE, PROLACTIN, AND URINARY FOLLICLE STIMULATING HORMONE AND LUTEINIZING HORMONE IN WOMEN PRESENTING IN WITH BENFERTILITY. Faculty of Pathology.
  30. Bickerstaff, H., & C. Kenny, L. (2017). Gynaecology by Ten Teachers . CRC Press. 33. Spencer, T. E., Johnson, G. A., Burghardt, R. C., & Bazer, F. W. (2004). Progesterone and placental hormone actions on the uterus: insights from domestic animals. Biology of reproduction, 71(1), 2-10.